NCT00437918View on ClinicalTrials.gov

The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions
Diabetes MellitusType 2 Diabetes Mellitus
Interventions
DRUG

nateglinide

DRUG

acarbose

Trial Locations (2)

614-735

Paik Diabetes Center, Pusan Paik Hospital, College of Medicine, Inje University, Busan

Unknown

Endocrinology and Metabolism, Maryknoll General Hospital, Busan

Sponsors

Collaborators (1)

Sanofi
All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Inje University

OTHER

NCT00437918 - The Effects of Nateglinide and Acarbose on the Post-Prandial Glucose Control in Type 2 Diabetic Patients | Biotech Hunter | Biotech Hunter